ÂÜÀòÂÒÂ×

John Lemkey is the current Chief Operating Officer at Odonate Therapeutics. Prior to joining Odonate, John served as the Chief Operating Officer at Tang Capital Management from April 2006 to December 2020. John has also held the position of Senior Auditor at Ernst and Young from August 2003 to April 2006.

John Lemkey attended the University of Southern California and graduated with a degree in accounting from the Marshall School of Business.

John Lemkey works with Joseph O’Connell - Chief Medical Officer, Stew Kroll - Chief Development Officer, and Thomas Wei - Chief Scientific Officer. John Lemkey reports to Kevin C. Tang, Chairman & CEO.